Levetira 500 mg (Tablet)
Unit Price: ৳ 30.00 (2 x 10: ৳ 600.00)
Strip Price: ৳ 300.00
Medicine Details
Category | Details |
---|---|
Generic | Levetiracetam |
Company | Popular pharmaceuticals ltd |
Also available as |
Indications
- Monotherapy for partial-onset seizures in adults and adolescents
- Adjunctive therapy for various types of seizures in adults, adolescents, children, and infants
Description
Mechanism of action is unknown, but Levetira inhibits burst firing without affecting normal neuronal excitability.
Dosage
- Recommended starting dose for adults and adolescents
- Dose adjustments for pediatric population
- Monotherapy and add-on therapy recommendations
Administration
Must be taken orally, swallowed with sufficient liquid, and can be taken with or without food. Daily dose is administered in two equally divided doses.
Interaction
- No influence on existing antiepileptic medicinal products
- Inhibition of renal clearance by probenecid
- Decrease in methotrexate clearance when administered concomitantly
- Reports of decreased efficacy when administered with osmotic laxative
- No alteration in absorption by food, but reduced rate of absorption
- No available data on interaction with alcohol
Contraindications
Hypersensitivity to active substance or other pyrrolidone derivatives or to any of the excipients
Side Effects
- Most common adverse reactions in adult and pediatric patients
Pregnancy & Lactation
Not recommended during pregnancy or breastfeeding, excreted in human breast milk, no impact on fertility detected in animal studies
Precautions & Warnings
- Dose adjustment in patients with renal impairment
- Rare cases of decreased blood cell counts
- Reported association with suicide attempts and behaviour
- Not adapted for use in infants and children under 6 years, impact on growth and puberty unknown
- Adjustment of dose in elderly patients with compromised renal function
Use in Special Populations
- Adjustment of the dose in elderly patients with compromised renal function
- Dose must be individualized according to renal function in patients with renal impairment
- No dose adjustment needed in patients with mild to moderate hepatic impairment, but reduction in daily maintenance dose recommended for severe hepatic impairment
Overdose Effects
- Symptoms observed with Levetira overdoses
- No specific antidote available
- Treatment will be symptomatic and may include haemodialysis
Therapeutic Class
Adjunct anti-epileptic drugs
Storage Conditions
Store at a cool temperature (not exceeding 25°C) and dry place, protected from light
Related Brands
- Levetira 500 mg/5 ml (Oral Solution) - popular-pharmaceuticals-ltd
- Levetam XR 500 mg (Tablet (Extended Release)) - eskayef-pharmaceuticals-ltd
- Neurocet 500 mg/5 ml (IV Infusion) - incepta-pharmaceuticals-ltd
- Levetam 500 mg (Tablet) - eskayef-pharmaceuticals-ltd
- Levetam 250 mg (Tablet) - eskayef-pharmaceuticals-ltd